Cell-free DNA captures tumor heterogeneity and driver alterations in rapid autopsies with pre-treated metastatic cancer
Bernard Pereira(University of Cambridge), Dejan Juric(Massachusetts General Hospital), M. Broudo(Harvard University), Rebecca Leary(Howard Hughes Medical Institute), James R. Stone(Harvard University), Supriya K. Saha(Diamond Harbour Women's University), Jeffrey A. Engelman(Cancer Research Center), Donna M. Fitzgerald(Massachusetts General Hospital), Islam Baiev(Massachusetts General Hospital), Lipika Goyal(Stanford Medicine), Laura E. Henderson(Harvard University), Wendy Winckler(Unknown), Charlotte S. Walmsley(Harvard University), Catarina D. Campbell(Broad Institute), Avinash Sahu(New Mexico Department of Health), A. Rose Brannon(Unknown), Xīn Gào(Qingdao University), Christopher T. Chen(Cancer Institute (WIA)), Christopher J. Pinto(Harvard University), Stephanie Reyes(Harvard University), Read Allen(Harvard University), Martin S. Taylor(Institute of Genetics and Cancer)
Cited by 74
Related Papers
Integrative genomics viewer
|Nature Biotechnology|2011|16.5k
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k